Journal of medical economics

Keyphrases

Publications

volume 27, number 1, 2024

Olalekan O Oluwole, Markqayne D Ray, Neil Davies, Rory Bradford, Calum Jones, Anik R Patel, Frederick L Locke
Cost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States: incorporating longer survival results. Journal of medical economics 27 (1) (2024)
Jennie H Best, Sheila R Reddy, Eunice Chang, Katalin Bognar, Marian H Tarbox, Steven E Cagas, Arpamas Seetasith
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals. Journal of medical economics 27 (1) (2024)
Olalekan O Oluwole, Markqayne D Ray, Neil Davies, Rory Bradford, Calum Jones, Anik R Patel, Frederick L Locke
Cost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States: incorporating longer survival results. Journal of medical economics 27 (1) (2024)
Shawn Davies, Emily Boller, Jordan G Chase, Anne Beaubrun, Cynthia Miller, Ivar Jensen
A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses. Journal of medical economics 27 (1) (2024)
G Tremblay, A Poirier, L Monfort
Value-based pricing: a potential solution to difficult pricing discussions and payers' negotiations. Journal of medical economics 27 (1) (2024)
Pratyusha Vadagam, Dexter Waters, Inyoung Lee, Justin Chen, Dajun Tian, Aimee M Near, Derek Lyle, Julie Vanderpoel
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type. Journal of medical economics 27 (1) (2024)
Panagiotis Petrou
Eliciting health state utilities in Japanese diabetic and obese patients through the time trade-off method. Does the conjecture fat and happy stand true? Journal of medical economics 27 (1) (2024)
Naleen Raj Bhandari, Adrienne M Gilligan, Julie Myers, Amine Ale-Ali, Lee Smolen
Integrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with RET -altered solid tumors in the US. Journal of medical economics 27 (1) (2024)
Scott E Kasner, Lars Sondergaard, Mitesh Nakum, Melissa Gomez Montero, Mahmoud Hashim, Erik J Landaas
A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke. Journal of medical economics 27 (1) (2024)
Scott E Kasner, Lars Sondergaard, Mitesh Nakum, Melissa Gomez Montero, Mahmoud Hashim, Erik J Landaas
A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke. Journal of medical economics 27 (1) (2024)
Ahmad Z Al Meslamani
Challenges in health economics research: insights from real-world examples. Journal of medical economics 27 (1) (2024)
Louis S Matza, Katie D Stewart, Josefine Redig, Timothy A Howell, Walter Morris, Rachel S Newson, Alexander Yasui, Jack Ishak, Kristina Secnik Boye
Health state utilities associated with weight loss: preferences of people with type 2 diabetes and obesity in Japan. Journal of medical economics 27 (1) (2024)
Naleen Raj Bhandari, Adrienne M Gilligan, Julie Myers, Amine Ale-Ali, Lee Smolen
Integrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with RET -altered solid tumors in the US. Journal of medical economics 27 (1) (2024)
Pratyusha Vadagam, Dexter Waters, Inyoung Lee, Justin Chen, Dajun Tian, Aimee M Near, Derek Lyle, Julie Vanderpoel
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type. Journal of medical economics 27 (1) (2024)
Ahmad Z Al Meslamani
Challenges in health economics research: insights from real-world examples. Journal of medical economics 27 (1) (2024)
Christine M Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He, Julie Vanderpoel
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. Journal of medical economics 27 (1) (2024)
Heather Sell, Kassandra Schaible, Julie A Gouveia-Pisano, Alon Yehoshua, Deepa Malhotra, Manuela Di Fusco, Ashley S Cha-Silva, Kathleen M Andersen, Lance Nicholls, Suzanne N Landi, Catherine Rolland, Jennifer Judy
Economic burden of COVID-19 for employers and employees in the United States. Journal of medical economics 27 (1) (2024)
Heather Sell, Kassandra Schaible, Julie A Gouveia-Pisano, Alon Yehoshua, Deepa Malhotra, Manuela Di Fusco, Ashley S Cha-Silva, Kathleen M Andersen, Lance Nicholls, Suzanne N Landi, Catherine Rolland, Jennifer Judy
Economic burden of COVID-19 for employers and employees in the United States. Journal of medical economics 27 (1) (2024)
Jonas Björnerstedt, Hannah Almqvist, Douglas Lundin, Niklas Zethraeus
Validation of overall survival extrapolations made by TLV in the assessment of cost-effectiveness of oncology drugs in Sweden - A pilot study comparing extrapolated and observed life-years gained. Journal of medical economics 27 (1) (2024)
Mavis Obeng-Kusi, Jennifer Martin, Ivo Abraham
The economic burden of Ebola virus disease: a review and recommendations for analysis. Journal of medical economics 27 (1) (2024)
Deborah R Kaye, Ibrahim Khilfeh, Erik Muser, Laura Morrison, Frederic Kinkead, Ana Urosevic, Patrick Lefebvre, Dominic Pilon, Daniel J George
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation. Journal of medical economics 27 (1) (2024)
Luke Schmerold, Coby Martin, Aashay Mehta, Dhruv Sobti, Ajit Kumar Jaiswal, Jatinder Kumar, Ian Feldberg, Malcolm G Munro, Won Chan Lee
A cost-effectiveness analysis of intrauterine spacers used to prevent the formation of intrauterine adhesions following endometrial cavity surgery. Journal of medical economics 27 (1) (2024)
Deborah R Kaye, Ibrahim Khilfeh, Erik Muser, Laura Morrison, Frederic Kinkead, Ana Urosevic, Patrick Lefebvre, Dominic Pilon, Daniel J George
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation. Journal of medical economics 27 (1) (2024)
Jennie H Best, Sheila R Reddy, Eunice Chang, Katalin Bognar, Marian H Tarbox, Steven E Cagas, Arpamas Seetasith
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals. Journal of medical economics 27 (1) (2024)
Luke Schmerold, Coby Martin, Aashay Mehta, Dhruv Sobti, Ajit Kumar Jaiswal, Jatinder Kumar, Ian Feldberg, Malcolm G Munro, Won Chan Lee
A cost-effectiveness analysis of intrauterine spacers used to prevent the formation of intrauterine adhesions following endometrial cavity surgery. Journal of medical economics 27 (1) (2024)
Daniel Mukadi, Antoine Nkuba-Ndaye, Placide Mbala-Kingebeni, Steve Ahuka-Mundeke, Jean-Jacques Muyembe-Tamfum
Impact of Ebola epidemics on the daily operation of existing systems in Eastern Democratic Republic of the Congo: a brief review. Journal of medical economics 27 (1) (2024)
Yong Wang, Chunxiao Liu, Chuan Liu, Yongji Lu, Lu Ban, Yuanjie Niu
Treatment patterns and healthcare resource utilization in patients with metastatic hormone-sensitive prostate cancer and nonmetastatic castration-resistant prostate cancer in China: a real-world observational study. Journal of medical economics 27 (1) (2024)

volume 27, number sup1, 2024

Gihan Hamdy Elsisi, Ang Yu Joe, Mollyza Mohd Zain, Habibah Mohd Yusoof, Cheng Lay Teh, Asmah Binti Mohd, Xiang Ting Khor, Liza Binti Mohd Isa
Economic burden of systemic lupus erythematosus in Malaysia. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Song-Chou Hsieh, Der-Yuan Chen
The economic burden of systemic lupus erythematosus in Taiwan. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Song-Chou Hsieh, Der-Yuan Chen
The economic burden of systemic lupus erythematosus in Taiwan. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Gerardo Quintana, Diana Gil, Pedro Santos, Diana Fernandez
Clinical and economic burden of systemic lupus erythematosus in Colombia. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Lilia Andrade-Ortega, Margarita Portela, Gabriel Medrano Ramírez
The economic burden of systemic lupus erythematosus in Mexico. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Song-Chou Hsieh, Der-Yuan Chen
The economic burden of systemic lupus erythematosus in Taiwan. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Ang Yu Joe, Mollyza Mohd Zain, Habibah Mohd Yusoof, Cheng Lay Teh, Asmah Binti Mohd, Xiang Ting Khor, Liza Binti Mohd Isa
Economic burden of systemic lupus erythematosus in Malaysia. Journal of medical economics 27 (sup1) (2024)
Atheer Alansari, Suad Hannawi, Afra Aldhaheri, Noura Zamani, Gihan Hamdy Elsisi, Sara Aldalal, Waiel Al Naeem, Mohamed Farghaly
The economic burden of systemic lupus erythematosus in United Arab Emirates. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Gerardo Quintana, Diana Gil, Pedro Santos, Diana Fernandez
Clinical and economic burden of systemic lupus erythematosus in Colombia. Journal of medical economics 27 (sup1) (2024)
Atheer Alansari, Suad Hannawi, Afra Aldhaheri, Noura Zamani, Gihan Hamdy Elsisi, Sara Aldalal, Waiel Al Naeem, Mohamed Farghaly
The economic burden of systemic lupus erythematosus in United Arab Emirates. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Ahmed Abogamal Waleed, Walid Al Shehhy, Mohamed Farghaly
Microsimulation model of the cost-effectiveness of anifrolumab compared to belimumab in the United Arab Emirates. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Lilia Andrade-Ortega, Margarita Portela, Gabriel Medrano Ramírez
The economic burden of systemic lupus erythematosus in Mexico. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Ahmed Abogamal Waleed, Walid Al Shehhy, Mohamed Farghaly
Microsimulation model of the cost-effectiveness of anifrolumab compared to belimumab in the United Arab Emirates. Journal of medical economics 27 (sup1) (2024)
Gihan Hamdy Elsisi, Lilia Andrade-Ortega, Margarita Portela, Gabriel Medrano Ramírez
The economic burden of systemic lupus erythematosus in Mexico. Journal of medical economics 27 (sup1) (2024)

volume 27, number sup2, 2024

Kayla Engelbrecht, Olga Ovcinnikova, Dionysios Ntais, Hayley Shoel, Anne Meiwald, Robert Hughes, Georgie Weston, Edith Morais, Goran Bencina
Productivity costs due to human papillomavirus-related cancer mortality in the United Kingdom. Journal of medical economics 27 (sup2) (2024)
Goran Bencina, Edward Oliver, Anne Meiwald, Robert Hughes, Edith Morais, Georgie Weston, Karin Sundström
Global burden and economic impact of vaccine-preventable cancer mortality. Journal of medical economics 27 (sup2) (2024)
Ugne Sabale, Eugenia Karamousouli, Lazar Popovic, Zoárd Tibor Krasznai, Daniel Harrop, Anne Meiwald, Robert Hughes, Georgie Weston, Goran Bencina
The indirect costs of human papillomavirus-related cancer in Central and Eastern Europe: years of life lost and productivity costs. Journal of medical economics 27 (sup2) (2024)
Ugne Sabale, Eugenia Karamousouli, Lazar Popovic, Zoárd Tibor Krasznai, Daniel Harrop, Anne Meiwald, Robert Hughes, Georgie Weston, Goran Bencina
The indirect costs of human papillomavirus-related cancer in Central and Eastern Europe: years of life lost and productivity costs. Journal of medical economics 27 (sup2) (2024)
Goran Bencina, Ugne Sabale, Edith Morais, Olga Ovcinnikova, Edward Oliver, Hayley Shoel, Anne Meiwald, Robert Hughes, Georgie Weston, Karin Sundström
Burden and indirect cost of vaccine-preventable cancer mortality in Europe. Journal of medical economics 27 (sup2) (2024)

volume 27, number sup3, 2024